126 related articles for article (PubMed ID: 22392066)
1. Simvastatin attenuated cerebrovascular cell proliferation in the development of hypertension through Rho/Rho-kinase pathway.
Ma MM; Li SY; Wang M; Guan YY
J Cardiovasc Pharmacol; 2012 Jun; 59(6):576-82. PubMed ID: 22392066
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin ameliorates rat cerebrovascular remodeling during hypertension via inhibition of volume-regulated chloride channel.
Liu YJ; Wang XG; Tang YB; Chen JH; Lv XF; Zhou JG; Guan YY
Hypertension; 2010 Sep; 56(3):445-52. PubMed ID: 20644009
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
6. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
7. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
Li RS; Wang Y; Chen HS; Jiang FY; Tu Q; Li WJ; Yin RX
Mol Med Rep; 2016 Apr; 13(4):3691-9. PubMed ID: 26955761
[TBL] [Abstract][Full Text] [Related]
8. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA Prevents Rat Basilar Artery Smooth Muscle Cells Proliferation by Inactivation of PDK1 During the Development of Hypertension.
Yu ZL; Wang JN; Wu XH; Xie HJ; Han Y; Guan YT; Qin Y; Jiang JM
J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):563-71. PubMed ID: 25736282
[TBL] [Abstract][Full Text] [Related]
10. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice.
Ohsawa M; Aasato M; Hayashi SS; Kamei J
Pain; 2011 Jan; 152(1):114-122. PubMed ID: 20980102
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
12. Restoration of uridine 5'-triphosphate-suppressed delayed rectifying K
Dai ZK; Kao CL; Hsieh SL; Chen IJ; Wu BN
Kaohsiung J Med Sci; 2016 Dec; 32(12):607-613. PubMed ID: 27914611
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
Zhang Z; Wang M; Xue SJ; Liu DH; Tang YB
Cardiovasc Drugs Ther; 2012 Feb; 26(1):31-40. PubMed ID: 22083280
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
[TBL] [Abstract][Full Text] [Related]
15. 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.
Rattan S
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G962-9. PubMed ID: 20378830
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
17. Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase.
Chen IC; Tan MS; Wu BN; Chai CY; Yeh JL; Chou SH; Chen IJ; Dai ZK
Pediatr Pulmonol; 2017 Apr; 52(4):443-457. PubMed ID: 28029743
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
19. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
Chrissobolis S; Budzyn K; Marley PD; Sobey CG
Stroke; 2004 Sep; 35(9):2200-5. PubMed ID: 15256679
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
